Literature DB >> 3554240

Development of a monoclonal antibody specifically reactive to gastrointestinal goblet cells.

M Vecchi, S Sakamaki, B Diamond, A B Novikoff, P M Novikoff, K M Das.   

Abstract

A mouse monoclonal antibody (7E6A5) of IgG isotype, reacting specifically with mucin-producing goblet cells of the human gastrointestinal tract, has been developed. 7E6A5 reacts by an ELISA with colonic protein eluted from a DEAE column. A screening by immunoperoxidase assay of 76 specimens from 19 different human tissues showed that the immunoreactivity of 7E6A5 was confined exclusively in the globules of goblet cells in the colon, the appendix, and the small intestine. Nongoblet small and large intestinal epithelial cells did not react. Immunoelectron microscopy demonstrated the reactivity with mucin droplets in a homogeneous granular pattern inside the globules of goblet cells. Mucus-secreting cells from remaining parts of the gastrointestinal tract and other mucus-secreting organs such as respiratory, genitourinary tracts, salivary and mammary glands did not show any reactivity to 7E6A5. These findings indicate that the antigen recognized by 7E6A5 is shared by the goblet cells of both the small and large intestines and is unique to them. The monoclonal antibody may be useful in the study of function of mucus-secreting goblet cells and may represent an important tool in the evaluation of diseases such as ulcerative colitis, colon cancer, and intestinal metaplasia in gastric mucosa that are associated with quantitative changes in goblet cell numbers or with qualitative differences in mucin secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3554240      PMCID: PMC304883          DOI: 10.1073/pnas.84.10.3425

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

Review 1.  Mucin histochemistry of the colon.

Authors:  M I Filipe; A C Branfoot
Journal:  Curr Top Pathol       Date:  1976

2.  Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.

Authors:  D K Podolsky; K J Isselbacher
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

Review 3.  The structure and physiology of gastrointestinal mucus.

Authors:  A Allen; A Bell; M Mantle; J P Pearson
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

Review 4.  Clinical aspects of gastrointestinal mucus.

Authors:  G Forstner; A Wesley; J Forstner
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

5.  Distribution of blood group substances in normal human colon. Use of the unlabeled antibody (PAP) immunoperoxidase technic to identify A and B blood group substances.

Authors:  E L Wiley; P Murphy; G Mendelsohn; J C Eggleston
Journal:  Am J Clin Pathol       Date:  1981-12       Impact factor: 2.493

6.  Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation.

Authors:  C R Boland; C K Montgomery; Y S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Immunocytochemical localization of epoxide hydrase in hyperplastic nodules induced in rat liver by 2-acetylaminofluorene.

Authors:  A B Novikoff; P M Novikoff; R J Stockert; F F Becker; A Yam; M S Poruchynsky; W Levin; P E Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Oligosaccharide structures of human colonic mucin.

Authors:  D K Podolsky
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

9.  Human large intestinal epithelium: light microscopy, histochemistry, and ultrastructure.

Authors:  A M Shamsuddin; P C Phelps; B F Trump
Journal:  Hum Pathol       Date:  1982-09       Impact factor: 3.466

10.  Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel.

Authors:  S Yonezawa; T Nakamura; S Tanaka; E Sato
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

View more
  7 in total

1.  In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis.

Authors:  T Hibi; M Ohara; K Toda; A Hara; H Ogata; Y Iwao; N Watanabe; M Watanabe; Y Hamada; K Kobayashi
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

2.  Hybridomas using athymic nude mouse injected with Crohn's disease (CD) tissue filtrate. Immunoreactivity of the hybridomas with CD sera.

Authors:  K M Das; M Vecchi; A Novikoff; S Mazumdar; P M Novikoff
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

3.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis.

Authors:  T S Halstensen; K M Das; P Brandtzaeg
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

4.  Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease.

Authors:  T Hibi; M Ohara; K Kobayashi; W R Brown; K Toda; H Takaishi; Y Hosoda; A Hayashi; Y Iwao; M Watanabe
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

5.  The presence in experimental animals of a colon specific Mr 40,000 protein(s) with relevance to ulcerative colitis.

Authors:  L Biancone; L S Wise; K M Das
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

6.  Characterization of the mucins produced by normal human colonocytes in primary culture.

Authors:  G Latella; R Fonti; R Caprilli; A Marcheggiano; F Magliocca; K M Das; G Gambús; Y Sambuy
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

7.  Mr 40,000 human colonic epithelial protein expression in colonic mucosa and presence of circulating anti-Mr 40,000 antibodies in cotton top tamarins with spontaneous colitis.

Authors:  K M Das; M Vecchi; L Squillante; A Dasgupta; M Henke; N Clapp
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.